Exact Mass: 308.0831

Exact Mass Matches: 308.0831

Found 21 metabolites which its exact mass value is equals to given mass value 308.0831, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

Alprazolam

12-chloro-3-methyl-9-phenyl-2,4,5,8-tetraazatricyclo[8.4.0.0²,⁶]tetradeca-1(10),3,5,8,11,13-hexaene

C17H13ClN4 (308.0829)


Alprazolam is only found in individuals that have used or taken this drug. It is a triazolobenzodiazepine compound with antianxiety and sedative-hypnotic actions, that is efficacious in the treatment of panic disorders, with or without agoraphobia, and in generalized anxiety disorders. (From AMA Drug Evaluations Annual, 1994, p238)Benzodiazepines bind nonspecifically to benzodiazepine receptors BNZ1, which mediates sleep, and BNZ2, which affects muscle relaxation, anticonvulsant activity, motor coordination, and memory. As benzodiazepine receptors are thought to be coupled to gamma-aminobutyric acid-A (GABAA) receptors, this enhances the effects of GABA by increasing GABA affinity for the GABA receptor. Binding of the inhibitory neurotransmitter GABA to the site opens the chloride channel, resulting in a hyperpolarized cell membrane that prevents further excitation of the cell. D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics > N05BA - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent

   

Dansylglycine

2-[5-(dimethylamino)naphthalene-1-sulfonamido]acetic acid

C14H16N2O4S (308.0831)


   

1-(2-Hydroxyethyloxymethyl)-6-phenyl thiothymine

1-[(2-hydroxyethoxy)methyl]-5-methyl-6-(phenylsulfanyl)-1,2,3,4-tetrahydropyrimidine-2,4-dione

C14H16N2O4S (308.0831)


D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D018894 - Reverse Transcriptase Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors

   

Liarozole

6-[(3-chlorophenyl)(1H-imidazol-1-yl)methyl]-1H-1,3-benzodiazole

C17H13ClN4 (308.0829)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D000726 - Androgen Antagonists C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C1740 - Aromatase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist D000970 - Antineoplastic Agents D003879 - Dermatologic Agents D004791 - Enzyme Inhibitors

   

colletopiperazine

colletopiperazine

C14H16N2O4S (308.0831)


   

alprazolam

alprazolam

C17H13ClN4 (308.0829)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics > N05BA - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent CONFIDENCE standard compound; INTERNAL_ID 1570

   

4-Amino-2,5-dimethoxy-N-phenylbenzenesulfonamide

4-Amino-2,5-dimethoxy-N-phenylbenzenesulphonamide

C14H16N2O4S (308.0831)


CONFIDENCE standard compound; INTERNAL_ID 974; DATASET 20200303_ENTACT_RP_MIX507; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3519; ORIGINAL_PRECURSOR_SCAN_NO 3515 CONFIDENCE standard compound; INTERNAL_ID 974; DATASET 20200303_ENTACT_RP_MIX507; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3526; ORIGINAL_PRECURSOR_SCAN_NO 3524 CONFIDENCE standard compound; INTERNAL_ID 974; DATASET 20200303_ENTACT_RP_MIX507; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3537; ORIGINAL_PRECURSOR_SCAN_NO 3535 CONFIDENCE standard compound; INTERNAL_ID 974; DATASET 20200303_ENTACT_RP_MIX507; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3517; ORIGINAL_PRECURSOR_SCAN_NO 3515 CONFIDENCE standard compound; INTERNAL_ID 974; DATASET 20200303_ENTACT_RP_MIX507; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3534; ORIGINAL_PRECURSOR_SCAN_NO 3531 CONFIDENCE standard compound; INTERNAL_ID 974; DATASET 20200303_ENTACT_RP_MIX507; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3552; ORIGINAL_PRECURSOR_SCAN_NO 3549

   

7-Chloro-1-methyl-5-phenyl-

7-Chloro-1-methyl-5-phenyl-

C17H13ClN4 (308.0829)


   

Pyrimido[1,2-a]benzimidazol-4-amine, N-(4-chlorophenyl)-2-methyl- (9CI)

Pyrimido[1,2-a]benzimidazol-4-amine, N-(4-chlorophenyl)-2-methyl- (9CI)

C17H13ClN4 (308.0829)


   
   

6,13-Pentacenedione

6,13-Pentacenedione

C22H12O2 (308.0837)


   

1,5-Aedans

1,5-Aedans

C14H16N2O4S (308.0831)


D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents D004396 - Coloring Agents > D005456 - Fluorescent Dyes

   

Piperidine, 1-((2,3-dihydro-2,3-dioxo-1H-indol-5-yl)sulfonyl)-4-methyl-

Piperidine, 1-((2,3-dihydro-2,3-dioxo-1H-indol-5-yl)sulfonyl)-4-methyl-

C14H16N2O4S (308.0831)


   

2-[2-(1,3-Dioxan-2-yl)ethanesulfinyl]-5-phenyl-1,3,4-oxadiazole

2-[2-(1,3-Dioxan-2-yl)ethanesulfinyl]-5-phenyl-1,3,4-oxadiazole

C14H16N2O4S (308.0831)


   

2-[(2-Ethoxy-2-oxoethyl)thio]-1-benzimidazolecarboxylic acid ethyl ester

2-[(2-Ethoxy-2-oxoethyl)thio]-1-benzimidazolecarboxylic acid ethyl ester

C14H16N2O4S (308.0831)


   

5-(2-methylpiperidin-1-yl)sulfonyl-1H-indole-2,3-dione

5-(2-methylpiperidin-1-yl)sulfonyl-1H-indole-2,3-dione

C14H16N2O4S (308.0831)


   

4-(2-phenylethylsulfamoyl)-1H-pyrrole-2-carboxylic acid methyl ester

4-(2-phenylethylsulfamoyl)-1H-pyrrole-2-carboxylic acid methyl ester

C14H16N2O4S (308.0831)


   

Liarozole

Liarozole

C17H13ClN4 (308.0829)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D000726 - Androgen Antagonists C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C1740 - Aromatase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist D000970 - Antineoplastic Agents D003879 - Dermatologic Agents D004791 - Enzyme Inhibitors

   

1-(2-Hydroxyethyloxymethyl)-6-phenyl thiothymine

1-(2-Hydroxyethyloxymethyl)-6-phenyl thiothymine

C14H16N2O4S (308.0831)


D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D018894 - Reverse Transcriptase Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors

   

6-hydroxy-3-(hydroxymethyl)-2-methyl-3-(methylsulfanyl)-10h,10ah-pyrazino[1,2-a]indole-1,4-dione

6-hydroxy-3-(hydroxymethyl)-2-methyl-3-(methylsulfanyl)-10h,10ah-pyrazino[1,2-a]indole-1,4-dione

C14H16N2O4S (308.0831)


   

(3r)-6-hydroxy-3-(hydroxymethyl)-2-methyl-3-(methylsulfanyl)-10h,10ah-pyrazino[1,2-a]indole-1,4-dione

(3r)-6-hydroxy-3-(hydroxymethyl)-2-methyl-3-(methylsulfanyl)-10h,10ah-pyrazino[1,2-a]indole-1,4-dione

C14H16N2O4S (308.0831)